CVS Health Corporation

CVS Healthcare Healthcare Plans

CVS Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $402.1 billion, up 7.85% from fiscal 2024. In the quarter to June 2026, revenue grew 7.26%, EPS grew 187.7%, free cash flow grew 338.3% and total debt fell 7.64%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten.

87.65 0.09 −0.10%
Market cap
$112.2B
P/E
22.9×
Fwd P/E
15.4×
Dividend yield
3.79%
F-score
7/9
Altman Z
2.26
Beneish M
−2.64
Dividend safety
43/100

CVS Health Corporation 10-Q filed Oct 29, 2025

Fiscal Q3 2025 · Period ended Sep 30, 2025 · Filed · accepted 6:34 AM ET · Document on sec.gov · Filing index

Red flags

  • Impairment

    CVS Health Corporation recorded a goodwill impairment of $5.7 billion in fiscal Q3 2025

    10-Q filed · The filing · sec.gov